Progressive Formulary Apportionment: The Case for 'Amount D'

171 Tax Notes Federal 1713 (2021)

16 Pages Posted: 17 Jul 2023

See all articles by Mitchell Kane

Mitchell Kane

New York University School of Law

Adam Kern

NYU Law

Date Written: July 8, 2021

Abstract

In this article, we introduce progressive formulary apportionment and urge that it be implemented within OECD’s Pillar One by establishing a new taxing right, which we call “Amount D.” Unlike traditional formulary apportionment, in which the rights to tax businesses are allocated on the basis of the transactional attributes of the firm—such as the firm’s payroll, assets, or sales—progressive formulary apportionment allocates at least some taxing rights on the basis of states’ economic well-being, with worse-off countries receiving more valuable rights, all else equal. We argue that progressive formulary apportionment has desirable distributional and efficiency characteristics and that it could be implemented seamlessly within the emerging architecture under Pillar One. The particular implementation that we propose, Amount D, is allocated to developing countries regardless of whether there is a nexus between the taxed firm and the taxing state.

Suggested Citation

Kane, Mitchell and Kern, Adam, Progressive Formulary Apportionment: The Case for 'Amount D' (July 8, 2021). 171 Tax Notes Federal 1713 (2021), Available at SSRN: https://ssrn.com/abstract=4504446

Mitchell Kane

New York University School of Law ( email )

40 Washington Square South
New York, NY 10012-1099
United States

HOME PAGE: http://rb.gy/swqd86

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
53
Abstract Views
184
Rank
718,511
PlumX Metrics